IDEAYA Biosciences (IDYA) Tops Q3 EPS by 3c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $8.04 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Carvana (CVNA) PT Lowered to $85 at RBC Capital